Have a personal or library account? Click to login

A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort

Open Access
|May 2019

References

  1. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012; 2: 210-25. 10.1016/j.clon.2012.03.008
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34. 10.3322/caac.21551
  3. Rades D, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Dunst J, et al. Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys 2007; 69: 1509-13.
  4. Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 2016; 388: 2004-14. 10.1016/S0140-6736(16)30825-X
  5. Rades D, Panzner A, Dziggel L, Haatanen T, Lohynska R, Schild SE. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. Cancer 2012; 118: 3853-9. 10.1002/cncr.26680
  6. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989; 39: 789-96.
  7. Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 2014; 32: 3810-6. 10.1200/JCO.2014.57.2909
  8. Brown PD, Pugh S, Laack N, Wefel JS, Khuntia D, Meyers C, et al.; Radiation Therapy Oncology Group (RTOG): Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 2013; 15: 1429-37. 10.1093/neuonc/not114
  9. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77: 655-61. 10.1016/j.ijrobp.2009.08.025
  10. Rades D, Dziggel L, Segedin B, Oblak I, Nagy V, Marita A, et al. A simple survival score for patients with brain metastases from breast cancer. Strahlenther Onkol 2013; 189: 664-7. 10.1007/s00066-013-0367-5
  11. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
  12. Rades D, Dziggel L, Nagy V, Segedin B, Lohynska R, Veninga T, et al. A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone. Radiother Oncol 2013; 108: 123-7. 10.1016/j.radonc.2013.06.009
  13. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, et al. Survival and neurologic outcomes in a randomizedtrial of motexafin gadolinium and whole-brain radia-tion therapy in brain metastases. J Clin Oncol 2003; 21: 2529-36. 10.1200/JCO.2003.12.122
  14. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-51.
  15. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database Int J Radiat Oncol Biol Phys 2008; 70: 510-4. 10.1016/j.ijrobp.2007.06.074
DOI: https://doi.org/10.2478/raon-2019-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 219 - 224
Submitted on: Feb 12, 2019
Accepted on: Mar 27, 2019
Published on: May 8, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.